Announced Thu, 2 Jul · 18:34 IST
Anthem Biosciences clarifies FY26 results filing discrepancies to NSE
Results View source PDF
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹773.00
prior close
₹779.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.5-0.5-0.5+0.0-1.0-2.3-2.7-2.3-3.0-0.5———
Up moveDown movePending
AI summary
NSE sought clarification on discrepancies in Anthem Biosciences' Q4 and FY26 financial results filed on May 19, 2026. The company stated that the FY26 PAT of INR 5,917.92 million is consistent across both the PDF and XBRL filings, with no actual mismatch. The omission of Consolidated EPS in the XBRL filing was attributed to an inadvertent clerical error. A revised XBRL filing incorporating the consolidated EPS will be submitted shortly.
Likely market impact
Minor clerical and disclosure filing issues only, no material financial impact. Revised XBRL filing with consolidated EPS to be submitted soon.